Sex, Renin Angiotensin System Inhibitors, and COVID-19 Severity: Biologic Divergence or Healthcare Disparity?
- PMID: 35984053
- PMCID: PMC9380151
- DOI: 10.1097/CCM.0000000000005613
Sex, Renin Angiotensin System Inhibitors, and COVID-19 Severity: Biologic Divergence or Healthcare Disparity?
Conflict of interest statement
The authors have disclosed that they do not have any potential conflicts of interest.
Comment on
-
Renin-Angiotensin System Pathway Therapeutics Associated With Improved Outcomes in Males Hospitalized With COVID-19.Crit Care Med. 2022 Sep 1;50(9):1306-1317. doi: 10.1097/CCM.0000000000005589. Epub 2022 May 18. Crit Care Med. 2022. PMID: 35607951 Free PMC article.
References
-
- Ozkan S, Cakmak F, Konukoglu D, et al. : Efficacy of serum angiotensin II levels in prognosis of patients with coronavirus disease 2019. Crit Care Med 2021; 49:e613–e623 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical